Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that more multidisciplinary research is needed to understand and treat PCOS, a condition that significantly affects women's health and quality of life.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

Birth control pills and anti-androgen medications help manage hair growth, acne, and hair loss in women with PCOS.

The article concludes that hormonal therapy is an effective long-term acne treatment, even for those without hormonal imbalances.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

Eating a balanced diet with specific nutrients is important for menopausal women to manage hair loss.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

New biomaterial treatments for baldness show promise, with options depending on patient needs.

Manipulating cell cleanup processes could help treat hair loss.

Skin problems in PCOS, like excess hair, acne, and hair loss, may not always indicate high male hormone levels and need careful diagnosis for proper treatment.

Oxidative stress increases in early hair loss, and family history plays a role; antioxidants may help future treatments.

The document concludes that hair loss in women is complex, often linked to aging, health conditions, and nutritional deficiencies, and emotional impacts should not be underestimated.

Analog 23 is a promising compound for prostate cancer treatment.

Low HDL-C, uric acid, and 25-hydroxyvitamin D are risk factors for early-onset male hair loss.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Father's finasteride use may affect son's fertility and testicular function.

The study suggests that treating early hair loss with Nourkrin® with Marilex® can help prevent further hair loss and may be linked to reducing the risk of lifestyle diseases.

Trazodone and chlorpromazine may help treat sexual dysfunction caused by finasteride and SSRIs.

Mutations in certain receptors can cause diseases and offer new treatment options.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

The new particle system could be a promising treatment for diseases related to the 5-α reductase enzyme.

The food supplement with L-cystine, Serenoa repens extract, and biotin safely reduced hair loss and improved hair growth in men and women.

Certain metabolites can either protect against or increase the risk of hair loss.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

TURP is the best treatment for BPH, but some patients prefer medications like alpha-blockers and finasteride.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Men with male pattern baldness had higher body fat and obesity-related measurements but similar heart fat and artery thickness compared to healthy men.